Opioid prescriptions for chronic nonmalignant pain

JAMA Internal Medicine

Volumn 173, Issue 3, 2013, Pages 178-

  Katz, Mitchell H ^a  

^a LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; OPIATE;

CAR DRIVING; CHRONIC PAIN; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEALTH CARE SYSTEM; HUMAN; PHYSICIAN; PRIORITY JOURNAL;

ACCIDENTS, TRAFFIC; ANALGESICS, OPIOID; DRUG TOXICITY; FEMALE; HUMANS; MALE;

EID: 84874051601     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.1838     Document Type: Editorial

References (3)

1. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011; 171(7):686-691.
2. Gomes T, Redelmeier DA, Juurlink DN, Dhalla IA, Camacho X, Mamdani MM. Opioid dose and risk of road trauma in Canada: A population-based study [published online January 14, 2013]. JAMA Intern Med. 2013;173(3):196-201.
3. Food and Drug Administration. Questions and answers: FDA approves a Risk Evaluation and Mitigation Strategy (REMS) for extended-release and longacting (ER/LA) opioid analgesics. http://www.fda.gov/Drugs/DrugSafety/ InformationbyDrugClass/ucm309742.htm. Accessed September 23, 2012.